ArticleInternational journal of molecular sciences2020

In Silico/In Vitro Hit-to-Lead Methodology Yields SMYD3 Inhibitor That Eliminates Unrestrained Proliferation of Breast Carcinoma Cells.

Ilham M Alshiraihi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.